| Typicality: | 0.531 |
| Saliency: | 0.279 |
| within 30 days after that day | 5 | temporal |
| by amgen | 2 | other |
| medicine → be sold in → canada | 12 |
| medicine → be marketed in → canada | 3 |
| negative | neutral | positive |
| 0.097 | 0.807 | 0.096 |
| Raw frequency | 15 |
| Normalized frequency | 0.279 |
| Modifier score | 1.000 |
| Perplexity | 108.767 |